Michael Grunebaum, M.D.
Associate Professor of Clinical Psychiatry
Columbia University Medical Center
Michael F. Grunebaum, M.D. is Assistant Professor of Clinical Psychiatry at Columbia University, and is a research psychiatrist at the New York State Psychiatric Institute. His areas of expertise include the diagnosis and treatment of mood disorders, with a focus on suicidal behavior and clinical trial research.
Dr. Grunebaum graduated magna cum laude and phi beta kappa from Harvard College in 1983 and received his M.D. from Harvard Medical School in 1991. He completed his residency in psychiatry at the Payne Whitney Psychiatric Clinic, New York Hospital-Cornell Medical Center, in 1995. He completed the Public Psychiatry Fellowship at Columbia University-New York State Psychiatric Institute and received his board certification in psychiatry in 1996.
Dr. Grunebaum is a recipient of a 2004 NARSAD Young Investigator award and an NIMH patient-oriented research career development K Award to conduct treatment studies in adults with Major Depressive Disorder and a history of suicidality. He is a research psychiatrist on other federally funded clinical studies of mood disorders and suicidal behavior in the Molecular Imaging and Neuropathology Division.
Dr. Grunebaum teaches psychiatry residents and other trainees. He is a peer reviewer for numerous psychiatric journals and a member of the American Psychiatric Association. He is an author of more than 40 peer reviewed articles and other publications.
Dr. Grunebaum also has a general adult private practice of psychotherapy and psychopharmacology.
Undergraduate: Harvard College, A.B., 1983
Medical School: Harvard Medical School, M.D., 1991
Internship: Mount Auburn Hospital/Harvard Medical School, Medical, 1991 - 1992
Residency: Payne Whitney Clinical Cornell University Medical Center, Psychiatry, 1992 - 1995
Fellowship: New York State Psychiatric Institute/Columbia University, Fellow, 1995 - 1996
Board Certifications: American Board of Psychiatry and Neurology
• Depression and bipolar disorder
• Anxiety disorders
• Borderline and other personality disorders
Click here for Dr. Grunebaum's Clinical Trials
NYS Psychiatric Institute
Room 2722 Unit/Box: 42
1051 Riverside Drive
New York, NY 10032
Clinical research on treatments for depression and suicidality.
1. Grunebaum MF, Ellis SP, Duan N, Burke AK, Oquendo MA, Mann JJ.: Pilot Randomized Clinical Trial of an SSRI vs Bupropion: Effects on Suicidal Behavior, Ideation, and Mood in Major Depression.. Neuropsychopharmacology 2012;37: 697-706
1. Grunebaum MF, Ellis SP, Li S, Oquendo MA, Mann JJ: Antidepressants and suicide risk in the United States, 1985-1999.. J Clin Psychiatry 2004 Nov;65(11): 1456-62
1. Grunebaum MF, Galfalvy HC, Oquendo MA, Burke AK, Mann JJ: Melancholia and the probability and lethality of suicide attempts.. Br J Psychiatry Jun 2004;184: 534-5
1. Grunebaum MF, Galfalvy HC, Huang YY, Cooper TB, Burke AK, Agnello M, Oquendo MA, Mann JJ. : Association of X-box binding protein 1 ( XBP1) genotype with morning cortisol and 1-year clinical course after a major depressive episode. Int J Neuropsychopharmacology 2009;75(3): 281-3
1. Grunebaum MF, Galfalvy HC, Mortenson LY, Burke AK, Oquendo MA, Mann JJ: Attachment and social adjustment: Relationships to suicide attempt and major depressive episode in a prospective study. J Affect Disord. 2009 Oct 8 2009;8: 123-30